Hla alleles associated with adverse drug reactions and...

Details Hla alleles associated with adverse drug reactions and... Hla alleles associated with adverse drug reactions and...

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01) C12Q 1/02 (2006.01) G01N 33/15 (2006.01) G01N 33/543 (2006.01) C12P 19/34 (2006.01)

Patent

CA 2651954

This invention relates to a method of determining the presence of certain HLA alleles, such as HLA-B*1502 or HLA-B*5801, and a kit for carrying out this method. Also disclosed is a method for assessing whether a patient is at risk for developing adverse drug reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis, or hypersensitivity syndrome) based on the presence or absence of a genetic marker (e.g., HLA-B*1502, HLA-B*5801, or HLA-B*4601).

L'invention concerne un procédé permettant de déterminer la présence de certains allèles de HLA, tels que HLA-B*1502 ou HLA-B*580, et un kit permettant de mettre en oeuvre ledit procédé. L'invention concerne également un procédé permettant d'évaluer le risque qu'un patient développe des réactions indésirables à un médicament (p. ex. Syndrome de Stevens-Johnson, nécrolyse épidermique toxique ou syndrome d'hypersensibilité) basées sur la présence ou l'absence d'un marqueur génétique (p. ex. HLA-B*1502, HLA-B*5801 ou HLA-B*4601).

Affiliated with

Also associated with

Rating

Hla alleles associated with adverse drug reactions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hla alleles associated with adverse drug reactions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hla alleles associated with adverse drug reactions and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1431003